ストックスクリーナーアプリを入手
0.826
1.08%
-0.009
アフターアワーズ：
.82
-0.006
-0.73%
前日終値:
$0.835
開ける：
$0.82
24時間の取引高:
1.96M
Relative Volume:
0.42
時価総額：
$243.47M
収益：
$55.87M
当期純損益:
$-77.60M
株価収益率:
-2.3157
EPS:
-0.3567
ネットキャッシュフロー:
$-79.46M
1週間 パフォーマンス:
-14.36%
1か月 パフォーマンス:
+44.10%
6か月 パフォーマンス:
-51.70%
1年 パフォーマンス:
-17.19%
1日の値動き範囲:
$0.7901
$0.8269
1週間の範囲:
$0.753
$1.01
52週間の値動き範囲:
$0.5277
$3.0699
Invivyd Inc Stock (IVVD) Company Profile
Compare IVVD vs VRTX, REGN, ARGX, MRNA, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IVVD
Invivyd Inc
|
0.826 | 280.26M | 55.87M | -77.60M | -79.46M | -0.3567 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Invivyd Inc Stock (IVVD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-22 | 開始されました | BTIG Research | Buy |
| 2025-11-25 | ダウングレード | D. Boral Capital | Buy → Hold |
| 2025-10-06 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-04-05 | アップグレード | Guggenheim | Neutral → Buy |
| 2024-03-26 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-19 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
| 2023-05-01 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Invivyd Inc (IVVD) 最新ニュース
Invivyd stock holds steady as investors watch recent trial progress - AD HOC NEWS
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Invivyd stock falls as investors await VYD2311 data - AD HOC NEWS
Director at Invivyd (IVVD) granted 100K stock options - Stock Titan
No Invivyd (NASDAQ: IVVD) shares listed in company director's ownership filing - Stock Titan
Invivyd appoints Marc Elia CEO amid board reshuffle - The Globe and Mail
Invivyd Inc (IVVD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
New multi-million-share option grant for Invivyd (IVVD) CEO - Stock Titan
Invivyd, Inc. Announces Board Appointments - marketscreener.com
New Haven COVID drugmaker names new CEO ahead of key trial results - Hartford Business Journal
Invivyd Names Chairman Marc Elia as CEO - marketscreener.com
Invivyd Names Marc Elia CEO, Adds New Independent Director as VYD2311 Phase 3 Studies Near Completion - Quiver Quantitative
Invivyd (IVVD) gives its new CEO rich equity and a potential 0.5%–1.5% payout on any sale worth at least $5B, as Phase 3 COVID antibody data near. - Stock Titan
Cantor Fitzgerald reiterates Invivyd stock rating on COVID trends - Investing.com
Invivyd (IVVD) Results Check: Profit Per Share Falls Below Its Benchmark on the Day; Price Move: The Stock Ends Up 2.65%Earnings Sentiment Score - vinanet.vn
Invivyd Stock (IVVD) Opinions on Upcoming Phase 3 Results - Moomoo
Invivyd (IVVD) Q1 2026 Results: The EPS Result Is Below Expectation; Closing Reaction: Shares Finish 10.53% Higher for the Current SessionEPS Revision Trend - vinanet.vn
FY2026 EPS Estimates for Invivyd Increased by HC Wainwright - MarketBeat
Invivyd CSO Robert Allen III sells $29,295 in stock By Investing.com - Investing.com South Africa
Invivyd chief legal officer Jill Andersen sells $52,780 in shares By Investing.com - Investing.com Australia
Invivyd CCO Timothy Lee sells $31,670 in shares By Investing.com - Investing.com Nigeria
Invivyd CFO William Duke sells $31,670 in company stock By Investing.com - Investing.com South Africa
Invivyd CFO William Duke sells $31,670 in company stock - Investing.com
Invivyd CHRO Julie Green sells $31,670 in company stock - Investing.com India
Invivyd CSO Robert Allen III sells $29,295 in stock - Investing.com
Invivyd chief legal officer Jill Andersen sells $52,780 in shares - Investing.com
Invivyd CCO Timothy Lee sells $31,670 in shares - Investing.com
Insider Selling: Invivyd (NASDAQ:IVVD) Insider Sells 18,425 Shares of Stock - MarketBeat
Insider Selling: Invivyd (NASDAQ:IVVD) Insider Sells $25,793.04 in Stock - MarketBeat
Invivyd (NASDAQ:IVVD) Insider Sells $26,824.32 in Stock - MarketBeat
Invivyd (IVVD) Closing Review: Moves 17.23% Up to $0.87; Current Setup: $0.83 and $0.91 Define the Nearby Reference Levels in Latest TradingLow Volatility Picks - vinanet.vn
Invivyd (IVVD) officer sells 37,256 and 30,706 shares under 10b5-1 plan - Stock Titan
H.C. Wainwright reiterates Invivyd stock rating on trial progress By Investing.com - Investing.com Canada
Invivyd (IVVD) Rises 2.72% to $0.74 as Buyers Defend Key Support at $0.70Rectangle Pattern - vinanet.vn
H.C. Wainwright reiterates Invivyd stock rating on trial progress - Investing.com
Invivyd CHRO Julie Green sells $31,670 in company stock By Investing.com - Investing.com Canada
IVVD Stock Tanks 19% Today – But This Analyst Believes It Has A Potential Upside Of Over 730% - Stocktwits
In vivodyne (NASDAQ: IVVD) holder plans 40,800-share sale - Stock Titan
Invivyd (NASDAQ: IVVD) insider plans 40,800-share sale - Stock Titan
Invivyd (NASDAQ: IVVD) holder to sell 40,800 shares after RSU vest - Stock Titan
Invivyd (NASDAQ: IVVD) holder plans sale of RSU-based shares - Stock Titan
Invivyd (NASDAQ: IVVD) holder to sell 37,741 shares via Morgan Stanley - Stock Titan
Invivyd’s Nasdaq Listing at Risk: Potential Delisting Threatens Financing Access and Market Value - The Globe and Mail
Invivyd Deadline Alert - TMX Newsfile
Invivyd (IVVD) sees 6.3% ownership reported by Perceptive Advisors group - Stock Titan
Invivyd (IVVD): BVF-led group discloses 29.6M shares, 9.99% beneficial stake - Stock Titan
Invivyd earnings missed by $0.03, revenue fell short of estimates - Investing.com Canada
Invivyd (NASDAQ:IVVD) Announces Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat
Invivyd, Inc. (IVVD) Reports Q2 Loss, Lags Revenue Estimates - Yahoo! Finance Canada
Invivyd, Inc. Q2 2026: Revenue $14.29M, EPS $(0.14) — 10-Q Summary - TradingView
Invivyd (IVVD) widens loss, warns on going concern as cash falls to $160M - Stock Titan
Invivyd Inc (IVVD) 財務データ
収益
当期純利益
現金流量
EPS
Invivyd Inc (IVVD) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Lee Timothy Edward | Chief Commercial Officer |
Aug 18 '26 |
Sale |
0.84 |
18,425 |
15,530 |
178,937 |
| Green Julie | Chief Human Resources Officer |
Aug 17 '26 |
Sale |
0.72 |
22,355 |
16,140 |
187,362 |
| Green Julie | Chief Human Resources Officer |
Aug 18 '26 |
Sale |
0.84 |
18,425 |
15,530 |
168,937 |
| Duke William E. | Chief Financial Officer |
Aug 17 '26 |
Sale |
0.72 |
22,355 |
16,140 |
187,362 |
| Duke William E. | Chief Financial Officer |
Aug 18 '26 |
Sale |
0.84 |
18,425 |
15,530 |
168,937 |
| Andersen Jill | Chief Legal Officer, Secretary |
Aug 17 '26 |
Sale |
0.72 |
37,256 |
26,899 |
314,480 |
| Andersen Jill | Chief Legal Officer, Secretary |
Aug 18 '26 |
Sale |
0.84 |
30,706 |
25,882 |
283,774 |
| Allen Robert D. III | Chief Scientific Officer |
Aug 17 '26 |
Sale |
0.72 |
20,679 |
14,930 |
195,808 |
| Allen Robert D. III | Chief Scientific Officer |
Aug 18 '26 |
Sale |
0.84 |
17,043 |
14,366 |
178,765 |
0.86%
0.31%
大文字化:
|
ボリューム (24 時間):